Stephen Henry Email & Phone Number
@aut.ac.nz
3 phones found area 718 and 408
LinkedIn matched
Who is Stephen Henry? Overview
A concise factual answer block for searchers comparing this professional profile.
Stephen Henry is listed as CEO and Managing Director at Kode Biotech, a company with 6 employees, based in Auckland, Auckland, New Zealand. AeroLeads shows a work email signal at aut.ac.nz, phone signal with area code 718, 408, and a matched LinkedIn profile for Stephen Henry.
Stephen Henry previously worked as Professor Emeritus at Auckland University Of Technology and Chief Technology Officer at Kode Veterinary Sciences. Stephen Henry holds Phd, Medicin Doctorsexamen from University Of Gothenburg.
Email format at Kode Biotech
This section adds company-level context without repeating Stephen Henry's masked contact details.
AeroLeads found 2 current-domain work email signals for Stephen Henry. Compare company email patterns before reaching out.
About Stephen Henry
I am the CEO/Managing Director and founder of the Kode Biotech group of companies (Kode Biotech, Kode Biotech Materials & GlycoNZ) and Professor Emeritus of AUT University. I am also a biological designer with the compelling vision that Kode Technology is a break-through technology and I have the passion and courage to make it happen. My mission is to make it easy for other businesses to incorporate Kode™ Technology and GlycoNZ products into their new products and/or R&D platforms. In 1996 I formed the biotechnology company Kode Biotech to develop "multi-functional bio-paint" aka Kode™ Technology conceived from my background in glycolipids. Together with my colleague and CSO Nicolai Bovin, the Kode™ Technology platform was designed, developed and reduced to practice. Protected by an extensive patent portfolio, Kode™ Technology is being used by a collaborative global research network, and generating revenue from multiple licensed products (with others in the pipeline). Kode™ Technology based products include blood diagnostic products introduced to the market in 2004 & 2007 by CSL, then R&D catalogue constructs in 2011 by Merck-MilliporeSigma, and in August 2018 BioLineRx took the immuno oncotherapeutic Kode™ Technology construct AGI-134 into human clinical trials. In 2015 Kode Biotech won the Supreme NZ Innovator Award for our contribution to this anti-cancer therapy innovation. I was elected a Fellow of the Royal Society of NZ in 2021.I originally trained as a medical laboratory scientist, specialising in immunohematology, and later undertook part-time university studies in science and business, including PhD’s in New Zealand (Auckland) and Sweden (Göteborg). My research, which later formed the basis of Kode™ Technology, resolved the serological, biochemical and genetic basis of various unusual blood group phenotypes, and the collaborative discovery of FORS, the 7th human carbohydrate blood group system. Although I am the CEO, I have a strong academic background in science, biotechnology and innovation and I have published or presented >200 scientific articles and I am an inventor on multiple patents/applications. After 24 years involvement with AUT University as a Professor I retired from academia in 2023 and now have the honorary title of Professor Emeritus at AUT University, School of Engineering.Please see www.kodecyte.org and www.glycoNZ.com for further details.
Listed skills include Biotechnology, R&D, Commercialization, Technology Transfer, and 15 others.
Stephen Henry's current company
Company context helps verify the profile and gives searchers a useful next step.
Stephen Henry work experience
A career timeline built from the work history available for this profile.
Professor Emeritus
Current
Chief Technology Officer
Current
Ceo/Managing Director
CurrentKode Biotech is an Auckland, New Zealand based company with a subsidiaries Kode Materials and GlycoNZ. We have developed an easy, fast, versatile, and controllable technology to modify biological surfaces (cells, viruses...) and non-biological surfaces (stainless steel, plastics...). Being able to easily change surface functionality has broad applications.
Chief Executive Officer
CurrentStephen Henry education
Phd, Medicin Doctorsexamen
Phd, Biochemistry
Diploma In Medical Laboratory Science - Nzcs Paramedical
Education record
Frequently asked questions about Stephen Henry
Quick answers generated from the profile data available on this page.
What company does Stephen Henry work for?
Stephen Henry works for Kode Biotech.
What is Stephen Henry's role at Kode Biotech?
Stephen Henry is listed as CEO and Managing Director at Kode Biotech.
What is Stephen Henry's email address?
AeroLeads has found 2 work email signals at @aut.ac.nz for Stephen Henry at Kode Biotech.
What is Stephen Henry's phone number?
AeroLeads has found 3 phone signal(s) with area code 718, 408 for Stephen Henry at Kode Biotech.
Where is Stephen Henry based?
Stephen Henry is based in Auckland, Auckland, New Zealand while working with Kode Biotech.
What companies has Stephen Henry worked for?
Stephen Henry has worked for Kode Biotech, Auckland University Of Technology, Kode Veterinary Sciences, and Glyconz.
Who are Stephen Henry's colleagues at Kode Biotech?
Stephen Henry's colleagues at Kode Biotech include Matthew Rosenberg.
How can I contact Stephen Henry?
You can use AeroLeads to view verified contact signals for Stephen Henry at Kode Biotech, including work email, phone, and LinkedIn data when available.
What schools did Stephen Henry attend?
Stephen Henry holds Phd, Medicin Doctorsexamen from University Of Gothenburg.
What skills is Stephen Henry known for?
Stephen Henry is listed with skills including Biotechnology, R&D, Commercialization, Technology Transfer, Entrepreneurship, Research, Immunology, and Drug Discovery.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial